Demand for farm loans is way up...but so are bankruptcies.

Demand for farm loans surged in the first quarter of the year, topping the previous record set in 2016.

Economists at the Kansas City Fed say that weaker crop prices over the past year have reduced farm income. That has led to lower loan repayment rates and more renewals and extensions. Last year, farm banks issued more than $115 billion in agricultural loans.

Meanwhile, farm bankruptcies are also on the rise. A University of Arkansas study shows more U.S. farms filed in the first three months of 2025 than in all of 2024.

Extension economist Ryan Loy says the 259 filings signal financial stress, similar to that seen in 2018 and 2019. He points to low commodity prices and higher costs for seed, fertilizer, and diesel.

Related Stories
Roger McEowen breaks down the EPA’s updated dicamba regulations and shares what farmers need to do to remain compliant under the new rules this growing season.
Jarrod Hardke with the University of Arkansas break down extreme drought conditions, shifting planting decisions, and the impact of rising input costs on Arkansas agriculture this season.
Louisiana farmers say high water levels routinely threaten crops, highlighting the need for critical infrastructure and sustainability efforts in the Bayou.
The Farm Monitor says Georgia farmers highlighted profitability and labor challenges during a Farm Bureau event with USDA Deputy Secretary Stephen Vaden.
Effort aims to reduce wildfire risk in Western Colorado communities
Rising costs and tighter margins are shaping the 2026 outlook.

LATEST STORIES BY THIS AUTHOR:

RFD-TV News contributor Roger McOwen covers important topics in ag law and taxation, including FBAR, Read Before Signing, Reporting 4-H Income, and Attorney-Client Privilege.
A five-year-old in Etheridge, Tennessee, lost his life in a grain auger. His mother shares her story to ensure that other farm families do not have to endure that pain. RFD-TV’s own Tammi Arender reports.
The U.S. government will give pharmaceutical company Moderna $176 million for a High-Path Avian Flu vaccine, Reuters reports.